CAMBRIDGE, Mass., Aug. 2 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its corporate presentation at the 26th Annual Canaccord Adams Summer Seminar. John Alam, M.D., Executive Vice President, Medicines Development and Chief Medical Officer of Vertex, will deliver the presentation on Tuesday, August 8, 2006 at 8:30 a.m. EDT.
The presentation will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcast will also be available on the Company’s website until August 22, 2006. To access the webcast, go to Vertex’s website and select the ‘Canaccord Adams 2006 Summer Seminar.’ To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. In collaboration with GlaxoSmithKline, Vertex co-discovered the HIV protease inhibitor, Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations, of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com/
Company News On-Call: http://www.prnewswire.com/comp/938395.html /
